We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Tepnel Appointed Preferred Supplier to AstraZeneca for DNA Extraction Services
News

Tepnel Appointed Preferred Supplier to AstraZeneca for DNA Extraction Services

Tepnel Appointed Preferred Supplier to AstraZeneca for DNA Extraction Services
News

Tepnel Appointed Preferred Supplier to AstraZeneca for DNA Extraction Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tepnel Appointed Preferred Supplier to AstraZeneca for DNA Extraction Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Tepnel Life Sciences PLC has announced that it has signed a global Master Services Agreement with AstraZeneca.

Under the terms of this agreement Tepnel has been appointed as a preferred supplier to AstraZeneca for DNA extraction services.

By continuing to provide a high quality service in the market Tepnel will have the opportunity to compete for further business and AstraZeneca will benefit from volume-related discounts.

Ben Matzilevich, CEO, commented, "Following our recent positive preliminary financial results for 2005 we are delighted at being able to announce more good news."

"AstraZeneca is already a valued client that has been working with us for a number of years and this agreement is proof of the high level of client service and technical expertise that we are able to deliver."

"This agreement further strengthens Tepnel’s position in the pharmaceutical industry as one of Europe’s largest providers of DNA extraction services."

Advertisement